CERUS CORP CERS

Latest FY: 2025 Healthcare Medical Devices
Market Price $2.98
Market Cap $569.05M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑16.1% YoY
$233.80M
3-Yr CAGR: 7.5%
Net Income ↑25.3% YoY
-$15.63M
Net Margin: -6.7%
Free Cash Flow ↓-87.0% YoY
$1.11M
FCF Yield: 0.19%
EPS (Diluted) ↑27.3% YoY
$-0.08
Basic: $-0.08
Return on Equity Efficiency
-24.3%
ROA: -310.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (CERS)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $39.3M $16.9M $-62.9M $-0.62 $-53.5M $-54.1M
FY 2017 $51.3M +30.7% $21.0M $-60.6M +3.7% $-0.56 +9.7% $-52.2M $-52.6M +2.8%
FY 2018 $76.1M +48.2% $29.3M $-57.6M +5.0% $-0.44 +21.4% $-31.2M $-32.4M +38.4%
FY 2019 $93.8M +23.3% $41.2M $-71.2M -23.8% $-0.51 -15.9% $-65.8M $-74.8M -130.9%
FY 2020 $114.2M +21.8% $50.8M $-59.9M +16.0% $-0.37 +27.5% $-40.7M $-42.4M +43.4%
FY 2021 $159.5M +39.6% $67.4M $-54.4M +9.2% $-0.32 +13.5% $-33.9M $-34.8M +17.8%
FY 2022 $188.3M +18.1% $87.1M $-42.8M +21.3% $-0.24 +25.0% $-25.6M $-27.6M +20.7%
FY 2023 $186.8M -0.8% $86.4M $-37.5M +12.4% $-0.21 +12.5% $-43.2M $-47.8M -73.0%
FY 2024 $201.3M +7.8% $99.5M $-20.9M +44.2% $-0.11 +47.6% $11.4M $8.5M +117.8%
FY 2025 $233.8M +16.1% $112.3M $-15.6M +25.3% $-0.08 +27.3% $4.8M $1.1M -87.0%
$

Valuation

Market Price $2.98
Market Cap $569.05M
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 9.31
FCF Yield 0.19%
Dividend Yield N/A
Shares Outstanding 200,369,000
%

Profitability & Margins

Gross Margin 48.03%
Operating Margin -3.71%
Net Margin -6.68%
Return on Equity (ROE) -24.33%
Return on Assets (ROA) -310.68%
Asset Turnover 46.48x
Revenue 3-Yr CAGR 7.48%
🛡️

Financial Health & Liquidity

Current Ratio 0.20
Cash Ratio 0.79
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $19.96M
Total Debt N/A
Book Value / Share $0.32
💧

Cash Flow Efficiency

Operating Cash Flow $4.84M
Capital Expenditures (CapEx) $3.73M
Free Cash Flow $1.11M
OCF / Revenue 2.07%
FCF / Revenue 0.47%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.08
EPS (Basic) $-0.08
Dividends / Share N/A
Book Value / Share $0.32
EPS YoY Growth 27.27%
🏛️

Balance Sheet (FY 2025)

Total Assets $5.03M
Total Liabilities $25.27M
Stockholders' Equity $64.22M
Current Assets $5.03M
Current Liabilities $25.27M